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Neonatal administration of clomipramine (CLI) produces physiological, 
neuroendocrinal and behavioral abnormalities in rats when they reach 
adulthood, which are similar to those observed in animal models of 
depression. In consummatory successive negative contrast (cSNC), rats that 
have had experience drinking 32% sucrose solution drink significantly less 
4% sucrose solution than rats that have drunk only 4% solution. It triggers 
an aversive-emotional reaction similar to fear or anxiety. We studied 
whether neonatal treatment with CLI alters the cSNC’s response in adult 
rats. The findings of the present work suggest that the neonatal treatment 
with an antidepressive could generate an increase tolerance to frustration in 
adult animals. CLI rats showed a faster recovery from the cSNC than control 
animals, which may be explained by an alteration of the Hypothalamic-
Pituitary-Adrenal axis (HPA), a serotonergic system deficit, a low 
expectative formation during pre-shift phase, or a combination of all these 
factors. 
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Administration of clomipramine (CLI), a serotonin and 
norepinephrine reuptake inhibitor, is commonly used for depression 
treatment. However, newborn animals treated with CLI exhibit behavioral 
and neurobiological abnormalities resembling endogenous depression in 
adult life (e.g., Vogel & Vogel, 1982; Vogel, Neill, Hagler & Kors, 1990a). 
Newborn rats treated with CLI show a decrease in their weight (e.g., de 
Boer, Mirmiran, van Haaren, Louwerse & van de Poll, 1989; Hansen & 
Mikkelsen, 1998; Maciag et al., 2006; Mirmiran et al., 1983), decreases 
pleasure-seeking behavior (Vogel, Neill, Hagler & Kors, 1990b), they were 
significantly less aggressive (e.g., Martínez-González, Prospero-García, 
Mihailescu & Drucker-Colın, 2002) and they increase immobility in a 
forced swim test, one of the most widely used procedures for the assessment 
of depressive behaviors (Baghya, Srikumar, Taju & Shankaranarayana Rao, 
2008; Bonilla-Jaime, Retana-Márquez, Vázquez-Palacios & Velázquez-
Moctezuma, 2003; Porsolt, Le Pichon & Jalfre, 1977; Vázquez-Palacios, 
Bonilla-Jaime & Velázquez-Moctezuma, 2005). Adding, they consume less 
of a 1% sucrose solution than controls in a preference test that was 
performed during two hours with animals deprived of food and water for 18 
hours, and that had received previous training of 48 hours of exposure to 
water and a 1% sucrose solution (Baghya et al., 2008). 
CLI rats have shortens the onset latency of REM sleep and increases 
REM sleep periods (Frank & Heller, 1997; Mirmiran, van de Poll, Corner, 
de Boer & van Oyen, 1980; Mirmiran, van de Poll, Corner, van Oyen & 
Bour 1981; Mirmiran et al., 1983; Vogel, Neill, Kors & Hagler, 1990) and 
produces permanent alteration of plasma corticosterone levels (e.g., 
Prathiba, Kumar & Karanth, 1998). CLI animals showed a lower increase of 
plasma corticosterone levels during the exposure to the stressor, and faster 
returned to basal levels. Similar results were found by others (Bonilla-Jaime 
et al., 2003). Besides CLI rats have an increase in their cholinergic activity 
(Mavanji & Datta, 2002; Prathiba, Kumar & Karanth, 2000) and Ogawa et 
al. (1994) showed that neonatal CLI treatment induced a lower response of 
the Hypothalamic-Pituitary-Adrenal axis (HPA) under a stressful situation. 
Otherwise, the neonatal CLI treatment produces a reduction in the 
serotonergic activity (Hansel & Mikkelsen, 1988). These results suggest 
that neonatal CLI treatment modifies the reactions to aversive situations. 
Furthermore, administration of antidepressants on adults rats treated with 
CLI during neonatal period reversed these changes (e.g., Nikiforuk & 
Popik, 2009, see Justel, Bentosela, Mustaca & Ruetti, 2011). 
A phenomenon that was not studied in this model is the animal 
response to incentive downshift or frustration. One of the used procedures 
to evaluate the behavior of the animals to the suddenly changes in the 
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reward's value is the consummatory Successive Negative Contrast (cSNC), 
in which rats receive daily access to a 32% sucrose solution (pre-shift 
phase) and then they are shifted to a 4% sucrose solution (post-shift phase). 
Compared to unshifted animals that always receive access to the 4% 
solution, downshifted rats exhibit a sharp suppression of consummatory 
behavior, followed by a recovery during the following 2-4 trials (e.g., 
Flaherty, 1996). This phenomenon causes changes similar to those triggered 
by stress or fear response (e.g., Gray, 1987). There is an increase of 
corticosterone after reward devaluation (Mitchell & Flaherty, 1998), among 
others alterations (Mustaca et al., 2007, 2009). 
While there is extensive evidence to justify that cSNC is a valid stress 
and “psychological pain” model (Papini, Wood, Daniel & Norris, 2006), 
little is known about the interactions between depression and cSNC. The 
data about the effects of antidepressives on cSNC are controversial. In a few 
studies in which antidepressants were administrated before the reward’s 
devaluation in cSNC, authors did not found any change in the response of 
those animals (e.g., Flaherty, Grigson & Demetrikopoulos, 1987; Flaherty 
et al., 1990). However, Becker (1986) reported that nonspecific serotonin 
antagonists, like cyproheptadine and cinanserine, produced potent contrast-
reducing action on the second post-shift trial, and Grigson and Flaherty 
(1991) showed that cyproheptadine reduced cSNC also during the first post-
shift trial. More recently, Nikiforuk and Popik (2009) training rats in an 
operant task under progressive ratio schedule of reinforcement with the 
break point (BP, the value of the last completed response ratio) as a 
behavioral endpoint. In the main experiment, a 32% sucrose solution was 
initially used as the reinforcer. Once the stable responding was achieved, for 
the following 5 days animals were treated once daily with the experimental 
drugs, and they were offered a 4% sucrose solution instead. In vehicle-
treated controls, the reduction of sucrose concentration resulted in a 
decrease in responding from a BP of about 40 (totaling 166 responses) to a 
BP of about 9 (totaling 22 responses). Fluoxetine and citalopram markedly 
inhibited this response decrement, while fluoxetine (6 mg/kg) augmented it. 
Neither desipramine nor morphine affected responding under the reduced 
sucrose concentration condition. The authors suggest that the 
antidepressants selectively inhibiting serotonin reuptake and a 
benzodiazepine anxiolytic and protect animals from the effects of a 
reinforcer downshift. 
The goal of the present study was to assess whether neonatal CLI 
treatment alters cSNC in adulthood (Experiment 2). Previously, a forced 
swim test was conducted to validate the neonatal CLI treatment procedure 
in our laboratory (Experiment 1).This work will offer the first evidence 
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about the relationship between an animal model of endogenous depression 
and a frustration model. The results obtained with CLI rats suggest that 
they will have an attenuated cSNC effect. 
EXPERIMENT 1: FORCED SWIM TEST 
METHOD 
Participants. Wistar male rats were experimentally naive and bred at 
the vivarium of our institution. Study procedures were approved by the 
Animal Care Committee and conformed to all the standards described in the 
Guide for the Care and Use of Laboratory Animals (National Research 
Council, 1996). 
Fifteen naive rats were used, CLI group (n = 7) and vehicle (VEH) 
group (n = 8). Animals had free access to food and water. The body weight 
was (means ± SE) 324±28 g in CLI-treated rats, and 374 ± 23 g in VEH-
treated rats. An ANOVA (CLI vs VEH) showed significant differences 
between CLI and VEH body weights, F(1,14) = 16.31, p< .001 indicating 
that neonatal CLI treatment induced a long-term negative effect in body 
weight gain. 
 
Neonatal treatment. From postnatal day 8 to 21, rats received 
subcutaneously administration of CLI (Novartis, Buenos Aires, Argentina, 
15mg/kg twice a day, dissolved in 0.9% saline solution, at 8.00 AM and 
8.00 PM) or saline solution (VEH). When animals were 90 days old, they 
were housed individually and behavioural testing begun. 
 
Apparatus and procedure. Rats were placed in a rectangular dark 
container (50 cm height, 30 cm wide) filled 30 cm high with water 
(24°C±3°C) for 5 min and the animal behavior was recorded using a Sony 
camera. Immobility (time spent still, making only small movements to hold 
the head above water; Porsolt et al., 1977; Velázquez-Moctezuma & Díaz-
Ruiz, 1992) was analyzed by a blind scorer. 
The forced swim test is one of the most widely used procedures for 
the assessment of depressive behaviors (Baghya et al., 2008; Bonilla-Jaime 
et al., 2003; Porsolt et al., 1977; Vázquez-Palacios et al., 2005). Because it 
was the first time that in our laboratory was used this neonatal treatment it 
was necessary to assess its validity.  
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Statistical analysis. Quantitative data were expressed as mean ± 
standard error mean (SEM) and ANOVA test were realized. Each goal 
tracking time (s) data for each animal was related to its body weight (g). An 
alpha level of statistical significance was set at 0.05.  
RESULTS 
Neonatal CLI rats remained motionless longer than those from VEH 
group, F(1,14) = 11.15; p < .005(data not shown) indicating the efficacy of 
CLI treatment according to previous results (Baghya et al., 2008; Bonilla-
Jaime et al., 2003; Porsolt et al., 1977, 1978; Vázquez-Palacios et al., 2005; 
Velázquez-Moctezuma & Ruiz-Díaz, 1992). 
EXPERIMENT 2: cSNC 
Participants. Twenty-eight naïve rats, CLI (n = 13) and VEH (n = 
15) were used. The body weight was 372±25 g in CLI, and 431±30 g in 
VEH-treated rats. ANOVA(CLI vs VEH) showed again differences in body 
weights, F(1,26) = 23.89, p< .0001. During the experiment, animals were 
maintained at 85% of their ad libitum weight, with free access to water. 
 
Apparatus and procedure. Four identical conditioning boxes (MED 
Associates, Vermont, USA) were used. Each box measured 24.1x 29.2 x 21 
cm (length x width x height). In the lateral wall there was a 5-cm hole, with 
a sipper tube. Goal-tracking time (measured in 0.01-s units) was 
automatically recorded by a computer that measured the cumulative amount 
of time that the photocell was activated during the trial. Goal-tracking time 
correlates with fluid intake for the two sucrose concentrations used in this 
experiment (Mustaca, Freidin & Papini, 2002). 
Animals from treatments CLI and VEH were matched by body weight 
and were randomly assigned to one of the following groups: CLI 32 (n = 7); 
VEH 32 (n = 8); CLI 4 (n = 6), and VEH 4 (n = 7), depending on the 
neonatal treatment (CLI or VEH) and the reward magnitude received during 
pre-shift phase (Trials 1-10, 32% or 4% sucrose solutions). During the post-
shift phase (Trials 11-15) all animals received access to the 4% sucrose 
solution. Each trial was 5 min duration.  
RESULTS 
Figure 1 shows the goal tracking time/body weight for each pair of 
groups during all training. 
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Figure 1. Top panel:  Pre-shift and post-shift phases of the cSNC in neonatal clomipramine 
(CLI)-treated groups. Animals were injected neonatally from postnatal day 8 to 21 with 
clomipramine. Bottom panel: Pre-shift and post-shift phases of the cSNC in neonatal vehicle 
(VEH)-treated groups. Animals were injected neonatally from postnatal day 8 to 21 with the 
vehicle solution. Results are expressed as mean ± SEM. * p<.05.    T/BW: Time (s) /Body 
Weight (g). 
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Pre-shift phase. Goal-tracking time increased gradually during pre-
shift phase. A Contrast (32%-4%) x Treatment (CLI-VEH) x Trial (1–10 
trials) ANOVA indicated significant effects of Treatment, F(1, 24) = 4,78,  
p< .04; Trial, F(9,216) = 22,79, p< .0004, and a Contrast x Trial interaction, 
F(9,216) = 2.52, p< .009. Separate ANOVAs of each trial and its 
correspondent LSD comparisons test on trials 1 to 3 showed significant 
differences between CLI 32 vs. CLI 4, VEH 32 and VEH 4 (Trials 1, 2 and 
3) and VEH 4 vs. CLI 4 and CLI 32 (Trial 4). ANOVAs of trials 4 to 10 did 
not show significant differences in any of the factors. In sum, during the 
first trials of the training the CLI 32 group consumed more sucrose solution 
than the other groups; nonetheless this difference was lost in the next trials. 
 
Post-shift phase. A Contrast x Treatment x Trial (11-15) ANOVA 
showed significant differences of Treatment, F(1, 24) = 4.34, p< .04; Trial, 
F(4,96) = 7.73, p< .0001; a Contrast x Trial interaction, F(4,96) = 18.23,   
p< .0001, and a Contrast x Treatment x Trial interaction, F(4,96) = 3.82,   
p< .006. Separate ANOVAs of each trial and its correspondent LSD 
comparisons test showed that CLI 32 vs CLI 4 groups differed on trial 11 
(p< .0003), VEH 32 vs VEH 4 groups on trials 11 and 12 (p< .04), and CLI 
32vs. VEH 32 on trial 11 (p< 0,003). Despite that the Figure 1 shows a 
decrease in the consume of the CLI 4 group, and this decrease would be the 
cause of the absence of the contrast effect in the CLI 32 group, the 
comparison between CLI 4 vs. VEH 4 groups in the trial 11 didn't show 
significant differences (p> 0.05). To corroborate this result, we realize an 
ANOVA between CLI 4 vs VEH 4 groups on the post-shift phase that only 
shows significant differences in Trial factor, F(4,44) = 9,82, p< 0,0001. The 
others factors didn't show significant differences. In summary, the animals 
that receive CLI neonatally presented a faster recovery of cSNC than 
animals without the neonatal treatment. 
DISCUSSION 
This is the first evidence that links an animal model of frustration with 
another of endogenous depression. The main results of this study indicated 
that CLI rats showed a cSNC effect only during the first downshift trial, 
while VEH animals showed this effect on two post-shift trials, which 
indicates a faster recovery of CLI animals. 
This result does not seem to be due to differences in sensitivity to 
sucrose solutions in CLI rats, because during the pre-shift phase all groups 
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had the same acquisition curve, even with increased intake of CLI 32 at the 
beginning of the training.  
The results are consistent with previous research that showed that 
neonatal administration of CLI may play an important role on the regulation 
of the stress responsiveness in adulthood. 
A similar result with CLI rats was found with the administration of a 
neonatal stress treatment on cSNC effect in adult rats (Ruetti, Justel, 
Mustaca, Torrecilla & González Jatuff, 2010). Suggestively that chronic 
random neonatal stress, just like that the CLI rats, produce a response‘ 
reduction of the Hypothalamic-Pituitary-Adrenal and same response of 
corticosterone in situation on stress (Ruetti et al., 2010). Seems like the 
response to appetitive reward devaluation of both neonatal treatments are 
associated with the same neurophysiological mechanisms. 
On the other hand, Amsel' theory (1992) suggests that the initial 
rejection of the 4% solution is triggered by a state of primary frustration 
induced by the discrepancy between the expectation of a 32% reward 
acquired during the pre-shift trials and the actual 4% reward encountered on 
the first post-shift trial. This initial emotional reaction (primary frustration) 
is hedonically aversive, and it induces rejection with minimal or no conflict, 
serving as an unconditioned stimulus for the acquisition of secondary 
frustration through Pavlovian conditioning (i.e., pairings of stimuli present 
at the time of reward downshift with the internal state of primary frustration 
(Amsel, 1992). Once acquired, secondary frustration plays its role as the 
avoidance component of the conflict induced at full strength during the 
second postshift trial. Also, the Amsel' theory predicts that the cSNC 
intensity depends on a magnitude discrepancy between the expectancy 
provoked during de pre-shift phase and the one obtained during the post-
shift phase, especially on secondary frustration. Although depressive 
subjects can evaluate correctly positive and negative rewards (e.g. 
McChargue, Spring, Cook & Neumann, 2004), their expectative formation 
might be altered due to amygdala dysfunctions (Abler, Erk, Herwig & 
Walter, 2007). Studies with humans show evidence of deficit in the 
evaluation of positive reinforcement and the formation of expectations in 
depressive patients (e.g., Layne, Merry, Christian & Ginn, 1982; 
Lewinsohn, Larson & Muñoz, 1982). On the basis of Amsel' theory (1992) 
the results suggest that the CLI and VEH rats expressed a same response 
pattern when they face to the downshift solution (unconditioned response), 
but the secondary frustration was attenuated may be because a diminished 
expectative in the CLI rats. 
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In summary, neonatal CLI treatment, which is a model of endogenous 
depression, induces a faster recovery from cSNC in adulthood (an animal 
model of frustration). The result may be explained by a low expectative 
formation during pre-shift phase, for an alteration of the HPA axis, a 
serotonergic system deficit, or a combination of all these factors. Further 
research is needed to elucidate these issues.  
RESUMEN 
Efecto del tratamiento neonatal con clomipramina sobre el Contraste 
Sucesivo Negativo consumatorio. La administración neonatal de 
clomipramina (CLI) produce alteraciones fisiológicas, neuroendocrinas y 
comportamentales en las ratas adultas, que son similares a las observadas en 
los modelos animales de depresión. En el Contraste Sucesivo Negativo 
consumatorio (CSNc), las ratas que recibieron una solución de sacarosa al 
32%, consumen menos de una solución de sacarosa al 4%, que los animales 
que siempre recibieron la solución 4%. Este modelo de devaluación del 
incentivo produce en los animales una reacción emocional similar al miedo 
y la ansiedad. En el presente trabajo, estudiamos si el tratamiento neonatal 
con CLI altera la respuesta de CSNc en ratas adultas. Los hallazgos del 
presente trabajo sugieren que el tratamiento neonatal con un antidepresivo 
podría generar un aumento en la tolerancia a la frustración en animales 
adultos. Los animales a los que se les administró neonatalmente CLI 
presentaron una recuperación más rápida en el CSNc, que los animales 
controles sin tratamiento neonatal. Este resultado puede explicarse por una 
alteración del eje Hipotálamo-Pituitario-Adrenal (HPA), por un deterioro del 
sistema serotoninérgico, por la formación de una baja expectativa durante la 
fase de pre-cambio, o por una combinación de estos factores. 
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